Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04774068Phase 1Completed
Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
Recurrent Anaplastic Large Cell LymphomaRecurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more
PrincipalinvestigatorStart date: 2021-09-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Swaminathan P Iyer, MD

M.D. Anderson Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Anaplastic Large Cell Lymphoma+2 more
Similarity Score17%

Christina Poh

City of Hope Medical Center

Related
3 trials

Shared therapeutic areas:

Recurrent Anaplastic Large Cell LymphomaRecurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRefractory Anaplastic Large Cell Lymphoma+1 more
Similarity Score13%

Nora Bennani, M.D.

Mayo Clinic in Rochester

Related
1 trials

Shared therapeutic areas:

Recurrent Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Anaplastic Large Cell Lymphoma+1 more
Similarity Score13%

Ann (Annie) W Silk

Dana-Farber - Harvard Cancer Center LAO

Related
1 trials

Shared therapeutic areas:

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRefractory Anaplastic Large Cell LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma+1 more
Similarity Score13%

Joselle Cook, M.B.B.S.

Mayo Clinic in Rochester

Related
1 trials

Shared therapeutic areas:

Recurrent Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Anaplastic Large Cell Lymphoma+1 more
Similarity Score13%

Alex F Herrera

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Recurrent Anaplastic Large Cell LymphomaRefractory Anaplastic Large Cell LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Similarity Score10%

Julio C Chavez

University Health Network Princess Margaret Cancer Center LAO

Related
1 trials

Shared therapeutic areas:

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Similarity Score10%

Roisin M Connolly

JHU Sidney Kimmel Comprehensive Cancer Center LAO

Related
2 trials

Shared therapeutic areas:

Recurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRefractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Similarity Score10%

Jasmine Zain, MD

City of Hope Medical Center

Related
2 trials

Shared therapeutic areas:

Recurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRefractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Similarity Score10%

Jasmine M Zain

City of Hope Medical Center

Related
1 trials

Shared therapeutic areas:

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04774068Phase 1PrincipalInvestigator

Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas

Recurrent Anaplastic Large Cell LymphomaRecurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more
Completed

All 1 trials loaded